Hao Nguyen

As a promising young surgeon-scientist, Nguyen was awarded the Department of Defense grant to interrogate the distinct ability of cancer cells to upregulate their stress response pathways upon oncogenic stress, chemotherapy and radiotherapy in order to evade cell death. In 2016, he received the PCF young investigator award and the AUA Rising Star in Research award to develop patient-derived xenograft (PDX) models to evaluate novel therapies for patients with neuroendocrine metastatic prostate cancer. In 2020, he received the 1 million-dollar PCF Challenge Grant to bring novel therapeutics for metastatic prostate cancer.

His clinical interest focuses on the early detection of prostate cancer using advanced imaging (PSMA PET/SPECT), novel biomarkers and MRI fusion biopsy in early diagnosis and treatment of prostate cancer. In 2019, he was appointed Benioff-Goldberg Endowed Professorship in Cancer Biology, Richard and Leilani Grinold Endowed Professorship in Urology and the recipient of the William R. Smart M.D Distinguished Teaching Award.